Correction: Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical trial. - Cai, Lin; Li, Chengxin; Li, Shanshan; Zhang, Xiaodong; Wang, Gang; Yu, Jianbin; Huang, Kun; Fang, Hong; Ding, Yangfeng; Wang, Jinyan; Jiang, Congjun; Lu, Qianjin; et al. (Dermatology & Therapy, 2025)